Table of contents

Extended reports

• p53 in rheumatoid arthritis synovial fibroblasts at sites of invasion (21 November, 2003)

  C A Seemayer, S Kuchen, M Neidhart, P Kuenzler, V Řihošková, E Neumann, M Pruschy, W K Aicher, U Müller-Ladner, R E Gay, B A Michel, G S Firestein, S Gay
• EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) (21 November, 2003)

  K M Jordan, N K Arden, M Doherty, B Bannwarth, J W J Bijlsma, P Dieppe, K Gunther, H Hauselmann, G Herrero-Beaumont, P Kaklamanis, S Lohmander, B Leeb, M Lequesne, B Mazieres, E Martin-Mola, K Pavelka, A Pendleton, L Punzi, U Serni, B Swoboda, G Verbruggen, I Zimmerman-Gorska, M Dougados
• Switching from NSAIDs to paracetamol: a series of n of 1 trials for individual patients with osteoarthritis (21 November, 2003)

  A C M Wegman, D A W M van der Windt, M de Haan, W L J M Devillé, C T Chin A Fo, Th P G M de Vries
• Does hydrotherapy improve strength and physical function in patients with osteoarthritis—a randomised controlled trial comparing a gym based and a hydrotherapy based strengthening programme (21 November, 2003)

  A Foley, J Halbert, T Hewitt, M Crotty
• Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study (21 November, 2003)

  L B A van de Putte, R Rau, F C Breedveld, J R Kalden, M G Malaise, P L C M van Riel, M Schattenkirchner, P Emery, G R Burmester, H Zeidler, H M Moutsopoulos, K Beck, H Kupper
• Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age (21 November, 2003)

  A M J Chorus, H S Miedema, A Boonen, Sj van der Linden
• Cancer incidence among patients with ankylosing spondylitis in Sweden 1965–95: a population based cohort study (21 November, 2003)

  N Feltelius, A Ekbom, P Blomqvist
• EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT) (21 November, 2003)

  B F Leeb, H A Bird, G Nesher, I Andel, W Hueber, D Logar, C M Montecucco, J Rovensky, J Sautner, M Sonnenblick
• Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense (21 November, 2003)

  R van Vollenhoven, A Harju, S Brannemark, L Klareskog
• Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study (21 November, 2003)

  A Theodoridou, L Bento, D P D’Cruz, M A Khamashta, G R V Hughes
• Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren’s syndrome: a randomised 12 week controlled study (21 November, 2003)

  N Tsifetaki, G Kitsos, C A Paschides, Y Alamanos, V Eftaxias, P V Voulgari, K Psilas, A A Drosos
• Sequence variations in the collagen IX and XI genes are associated with degenerative lumbar spinal stenosis (21 November, 2003)

  N Noponen-Hietala, E Kyllönen, M Männikkö, E Ilkko, J Karppinen, J Ott, L Ala-Kokko
• Osteocyte viability with glucocorticoid treatment: relation to histomorphometry (21 November, 2003)

  P N Sambrook, D R Hughes, A E Nelson, B G Robinson, R S Mason